Source: U-Swirl management
We have recently launched the offering of U-Swirl-n-Go Store franchises, which are limited-product stores within non-traditional locations, such as convenience stores, airports, hotels and other mass gathering areas. The initial investment for these franchises is substantially less and flat royalty fees, instead of fees based on a percentage of revenues, are charged.
We also intend to offer franchises for a limited-product store (a “U-Swirl-n-Go Store”) within a non-traditional location, such as a convenience store, airport, or hotel. U-Swirl-n-Go Stores will typically offer four to six flavors of self-service yogurt, with customers filing containers with as much of one or more flavors as desired, selecting from over 40 toppings, and then paying by the ounce for the yogurt and toppings. U-Swirl-n-Go Stores will typically occupy 50 square feet or less within the non-traditional location, and with no dedicated seating.
Management is also continuing its efforts to expand product offerings, including co-branding arrangements. Some of the cafés will have co-branded Rocky Mountain Chocolate Factory products, while others may have co-branding arrangements with different entities.
We intend to grow organically by expanding the number of locations under construction through continued development of the growing franchise base. We intend to incentivize through co-branding with proprietary concepts, and capitalize on synergistic opportunities for joint-venture cafés. We intend to leverage the RMCF relationship, utilizing its experience in logistics, franchising, and international markets to expand market share. Based on an analysis of population statistics, we believe that an estimated 3,000 U-Swirl owned cafés could be operated in the United States and abroad. These estimates are based on a variety of factors including total population, population density, drive-time and other factors related to consumer convenience, consumer demand, local market competition and other relevant factors. In addition, we believe that foreign markets represent expansion opportunities as well. There can be no assurances that we can or will be able to successfully develop and operate the estimated 3,000 potential cafés in the United States.
Thugs at Vyteris stole assets of the company including patents? Phase 3 ready female infertility patch. What a bunch of criminals including Dr Eugene Baeur, Joseph Himy and Haro Hartounian and co. Shame on you all jerks to destroy this great company and steal everything imho
Vyteris has almost 100 patents in Transdermal drug delivery and an FDA approved needle less blood draw device LidoSite ready to be marketed. Also has promising phase 3 ready female infertility patch. NuPathe should grab it all to have its pipeline diversified just in case migraine patch fails to get FDA approval. If that happened it would put an end to the company. Buying out Vyteris (VYTR) assets allows to gain an edge in the transdermal drug delivery market. Should start phase 3 trials for multi billion dollar female infertility imho
Wish idiot Dr Eugene Baeur & team puts in some efforts into licensing the products and selling the nearly 100 patents held by Vyteris. All of it could be fetch $50 mln to $100 mln. Still hopeful someday soon we hear some good news imho
Use the $27 mln cash now on hand to buyout all the patents and phase 3 ready promising female infertility transdermal patch from Vyteris (VYTR) for $5 mln. It will make PATH valuation rise by $25 mln as it will have a late stage product with billions of dollars of market potential. Strengthen patent portfolio and diversify pipeline for peanuts imho
Sentiment: Strong Buy
World Class losers like Eugene Baeur, Haro Hartounian, Joseph Himy and others at Vyteris ruined this great company. Shame on you all useless idiots imho
Keep your eyes on VYTR - huge blocks on buy side on level 2. VVUS is ripe now. Get into VYTR that can rise 1000% like VVUS run imho
Vyteris (VYTR) has FDA approved device that draws blood without the help of Needle. Like Obesity you know female infertility is a multi billion dollar market globally imho
VYTR - Vyteris ($0.03) - FDA approved product LIDOSITE which is needle free blood draw device / Female Infertility phase 3 drug ready promising transdermal patch ready to be licensed = BILLIONS of DOLLARS market potential. Don't missout on making 800% like VVUS. I told you buy VVUS under $5 but no one listened imho
I loaded VVUS and made big bucks but missed our on ARNA. If you wanna make 1000% or more like VVUS or ARNA run than load up some VYTR at today's dirt cheap price imho
Vyteris (VYTR:$0.03) = FEMALE INFERTILITY Phase 3 / BILLIONS in potential. Also has FDA approved needle less blood draw device which has BILLIONS OF DOLLARS market potential as well. Vyteris can rise 1000% or more like ARNA imho
Vyteris licensing of phase 3 ready promising female infertility transdermal patch could fetch $50 mln+ imho
Deal getting sealed? Someone knows something? 100k block buy on level 2 now. Never seen such large block on buy for so long. Something's brewing for sure. May be we will see $0.20+ soon imho
Call - email
Kevin Kimberline at
Phone: (800) 622-7078
Dr Eugene Baeur
Home address: 59 Montecito Road, San Rafael, CA 94901
ARNA & VVUS up 600% in 2 yrs, wish I bought those stocks and not this garbage run & ruined by losers like Haro Hartounian, Joseph Himy, Eugene Baeur, Kevin Kimberline, Joel Kanter imho
NuPathe should buyoout assests that includes close to 100 patents in transdermal drug delivery, phase 3 ready female infertilty patch and several other pipeline products including FDA approved needle less blood draw equipment LidoSite. Pay like $20 mln to Vyteris (VYTR) and you can have it all. With right execution all the assests should be worth $500 mln down the road imho.
Just open an account on LinkedIn, its free. Do some lookup on their names on Google and Yahoo and you will find their contact info. Its easy imho.
My garbage collector must be 1000 times smarter than Dr Eugene Baeur. What a bunch of world class losers this company found - sad but true imho